- Patent Title: Substituted carbonucleoside derivatives useful as anticancer agents
-
Application No.: US15612030Application Date: 2017-06-02
-
Publication No.: US10220037B2Publication Date: 2019-03-05
- Inventor: John Howard Tatlock , Indrawan James McAlpine , Michelle Bich Tran-Dube , Eugene Yuanjin Rui , Martin James Wythes , Robert Arnold Kumpf , Michele Ann McTigue , Ryan Patman
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent David Rubin
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; C07D519/00 ; A61K31/137 ; A61K31/53 ; C07D237/22 ; C07D251/16 ; C07D471/06 ; C07D239/42 ; C07D239/84 ; C07D251/18 ; C07D491/048 ; A61P35/00 ; A61P35/02 ; A61P35/04 ; A61K31/02 ; C07C255/34
Abstract:
Compounds of the general formula): processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
Public/Granted literature
- US20170348313A1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS Public/Granted day:2017-12-07
Information query
